FDA official logo
GSRS logo
PFDA official logo

SECUKINUMAB

  • UNII: DLG4EML025
  • Preferred Substance Name: SECUKINUMAB

  • 1229022-83-6
  • AIN457
  • AIN-457
  • AIN457A
  • COSENTYX
  • COSENTYX (INITIAL APPROVAL)
  • COSENTYX (PARTIAL CHANGE APPROVAL)
  • IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A)), HOMO SAPIENS MONOCLONAL ANTIBODY
  • SECUKINUMAB (GENETICAL RECOMBINATION)
  • SECUKINUMAB [INN]
  • SECUKINUMAB [JAN]
  • SECUKINUMAB [MI]
  • SECUKINUMAB [PURPLE BOOK, CDER]
  • SECUKINUMAB [USAN]
  • SECUKINUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.